Office polypectomy (n = 324) | Inpatient polypectomy (n = 75) | p value | ||
---|---|---|---|---|
Age (years) | Mean (SD) | 53 (11) | 51 (12) | p = 0.2 |
BMI (kg/m2) | Mean (SD) | 31 (8)a | 31 (8)b | p = 0.7 |
Ethnicity | White | 263 (91 %) | 54 (93 %) | p > 0.9 |
Asian | 12 (4 %) | 2 (3 %) | ||
Black | 8 (3 %) | 1 (2 %) | ||
Other | 6 (2 %) | 1 (2 %) | ||
Not given/not known | 35 | 17 | ||
Recruiting centre | BWHc | 105 (32 %) | 24 (32 %) | p = 0.5 |
RHHd | 60 (19 %) | 18 (24 %) | ||
Otherse | 159 (49 %) | 33 (44 %) | ||
Predominant bleeding complaint at randomisation | Post-menopausalf | 155 (48 %) | 37 (49 %) | p = 0.2 |
Heavy menstrualg | 75 (23 %) | 23 (31 %) | ||
Intermenstrualh | 94 (29 %) | 15 (20 %) | ||
Site of uterine polyp | Fundal | 118 (36 %) | 25 (33 %) | p = 0.6 |
Non-fundal | 206 (64 %) | 50 (67 %) | ||
Type of uterine polyp | Glandular | 229 (71 %) | 53 (71 %) | p > 0.9 |
Fibrous | 95 (29 %) | 22 (29 %) | ||
Number of polyps | 1 | 233 (72 %) | 58 (77 %) | p = 0.6 |
2 | 62 (19 %) | 11 (15 %) | ||
> = 3 | 29 (9 %) | 6 (8 %) | ||
Parity | 0 | 49 (15 %) | 18 (24 %) | p = 0.4 |
1 | 35 (11 %) | 6 (8 %) | ||
2 | 121 (37 %) | 26 (35 %) | ||
3 | 50 (15 %) | 9 (12 %) | ||
> = 4 | 37 (11 %) | 8 (11 %) | ||
missing | 32 (10 %) | 8 (11 %) | ||
Other benign pathology | None | 318 (98 %) | 74 (99 %) | p = 0.8 |
SMF/Adhesion/Septum | – | – | ||
Adhesion/Septum | – | – | ||
SMF | 5 (2 %) | 1 (1 %) | ||
Septum | 1 (<1 %) | – |